search
Back to results

Reticulospinal Control of Movements

Primary Purpose

Spinal Cord Injuries, Healthy

Status
Recruiting
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Startling acoustic stimulus
Sponsored by
University of Zurich
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Spinal Cord Injuries

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Written informed consent as documented by signature

For SCI patients:

  • ASIA Impairment scale (AIS) A-D
  • Focal damage at cervical (C4-C7; i.e. damage rostral of the spi-nal segments innervating the examined hand and leg muscles) or thoracic (T4-T12; i.e. damage caudal of the spinal segments innervating the m. abductor digiti minimi, but rostral of the spi-nal segments innervating the m. tibialis anterior)
  • Patients with cervical SCI must reveal bilaterally intact ulnar nerves as demonstrated by normal compound motor action potential (cMAP), nerve conduction velocity (NCV) and F-wave latencies in clinical neurography.
  • Patients with thoracic SCI must reveal bilaterally intact tibial and peroneal nerves as demonstrated by normal cMAP, NCV and F-wave latencies

Exclusion Criteria:

  • Women who are pregnant or breast feeding
  • Current neurological problems other than SCI and related impairments
  • Current orthopaedic problems affecting upper and lower extremity movements
  • History of alcohol abuse or the intake of psychotropic drugs
  • History of major cardiac condition (e.g., infarction, insufficiency (NYHA II-IV))
  • History of major pulmonary condition (e.g., chronic obstructive pulmonary disease (GOLD II-IV))
  • Current major depression or psychosis
  • Fever of unknown origin

Sites / Locations

  • Balgrist University HospitalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Spinal cord injured subjects

Arm Description

Outcomes

Primary Outcome Measures

EMG analysis (i.e. shortening of movement reaction time of target muscle(s)) during Loud vs. Moderate Acoustic Stimuli (LAS vs. MAS)
Change in EMG analysis (i.e. shortening of movement reaction time of target muscle(s))
Change in EMG analysis (i.e. shortening of movement reaction time of target muscle(s))
Intramuscular coherence of paired EMG signals of the tibialis anterior muscle to assess corticospinal drive in the StartReact paradigm.
Modulation of EMG reflex responses (as induced by electrical ulnar nerve stimulation) by simultaneous acoustic stimulation with LAS
Transcranial magnetic stimulation (TMS) to investigate corticospinal physiology/ integrity.

Secondary Outcome Measures

Analysis of movement patterns of fast vs. slow movements based on 3D kinematics.
Endpoint accuracy of fast vs. slow reaching and stepping movements based on a combined Virtual Reality (VR)/ kinematic system.
Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) to measure upper extremity function (only for SCI)
International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) (only for SCI)
10-meter walk test (only for SCI)
6-minute walk test (only for SCI)
Modified Ashworth Scale (MAS) (only for SCI)

Full Information

First Posted
May 26, 2021
Last Updated
August 24, 2023
Sponsor
University of Zurich
search

1. Study Identification

Unique Protocol Identification Number
NCT04967274
Brief Title
Reticulospinal Control of Movements
Official Title
Contributions of the Reticulospinal System to Movement Control and Functional Recovery in Patients With Spinal Cord Injury
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 15, 2022 (Actual)
Primary Completion Date
June 30, 2026 (Anticipated)
Study Completion Date
June 30, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Zurich

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Accurate movement execution is a result of a complex interplay between various muscle groups whose activity is controlled by different areas of the central nervous system. Besides the corticospinal system, the phylogenetically old reticulospinal system is a key motor system controlling different elementary movements including posture, locomotion and reaching across all mammals. In contrast to the extensively investigated corticospinal system, there is only sparse knowledge on the motor physiology of the functionally important reticulospinal system in humans. Reticulospinal motor control can be assessed with the StartReact paradigm which is based on the activation of reticulospinal motor circuitries by startling acoustic stimuli. The StartReact phenomenon is characterized by a shortening in movement reaction time which is mediated by a startle-triggered, early release of a planned motor program by the reticulospinal system. Thus, StartReact is a unique tool to examine reticulospinal involvement on human motor control under physiological and pathological conditions. StartReact assessments will be supplemented by comprehensive 3-D kinematic analysis and muscle activity recordings (i.e. electromyography) to gain quantitative insights into reticulospinal movement control. The first objective of this clinical study is to gain more insights into the mechanisms underlying StartReact and to advance the knowledge on reticulo-spinal motor physiology regarding different movement tasks (i.e. simple single-joint movements, complex multi-joint movements and bilateral hand movements) in healthy subjects. The findings of these experiments will provide new insights into proximal-distal, flexor-extensor and upper-lower extremity gradients in reticulospinal motor control of healthy subjects. Moreover, the results will expand the StartReact paradigm to complex, functionally more relevant movements (i.e. reaching and stepping tasks requiring endpoint accuracy; co-operative, bilateral hand movements) for which the involvement of the reticulo-spinal system is not yet understood. The second goal of this project is to use the StartReact paradigm to shed more light onto the role of reticulospinal plasticity in functional recovery of patients with spinal cord injury (SCI). Whereas preclinical findings emphasize a remarkable potential of the reticulospinal system for neuroplastic adaptations underlying functional recovery, there is only little evidence from clinical trials in the field of SCI. First, the study aims at monitoring StartReact effects in hand and leg muscles of patients with acute SCI over a period of 6 months. Simultaneous tracking of StartReact effects and motor recovery will allow to closely relate processes of reticulospinal plasticity to functional recovery in patients with acute SCI. Second, the focus will be on the re-weighting of descending motor control (i.e. cortico- vs. reticulospinal system) in response to SCI and investigate the distinct contributions of the cortico- and reticulospinal system to motor recovery in patients with chronic SCI. The findings of this project will advance the mechanistic understanding on the motor physiology and neurorestorative capacity of the reticulospinal system in humans. New insights from these projects will hopefully translate into a better exploitation of this important motor system in clinical trials that aim to improve motor recovery in patients with SCI.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injuries, Healthy

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Each participants receives real and control interventions.
Masking
None (Open Label)
Allocation
N/A
Enrollment
155 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Spinal cord injured subjects
Arm Type
Experimental
Intervention Type
Procedure
Intervention Name(s)
Startling acoustic stimulus
Intervention Description
StartReact: involuntary triggering of a planed movement by a loud acoustic stimulus.
Primary Outcome Measure Information:
Title
EMG analysis (i.e. shortening of movement reaction time of target muscle(s)) during Loud vs. Moderate Acoustic Stimuli (LAS vs. MAS)
Time Frame
Baseline
Title
Change in EMG analysis (i.e. shortening of movement reaction time of target muscle(s))
Time Frame
Change in shortening of movement reaction time between baseline and visit 1 (7-14 days).
Title
Change in EMG analysis (i.e. shortening of movement reaction time of target muscle(s))
Time Frame
Change in shortening of movement reaction time at 3 and 6 months relative to baseline.
Title
Intramuscular coherence of paired EMG signals of the tibialis anterior muscle to assess corticospinal drive in the StartReact paradigm.
Time Frame
Baseline
Title
Modulation of EMG reflex responses (as induced by electrical ulnar nerve stimulation) by simultaneous acoustic stimulation with LAS
Time Frame
Baseline
Title
Transcranial magnetic stimulation (TMS) to investigate corticospinal physiology/ integrity.
Time Frame
Baseline
Secondary Outcome Measure Information:
Title
Analysis of movement patterns of fast vs. slow movements based on 3D kinematics.
Time Frame
Baseline
Title
Endpoint accuracy of fast vs. slow reaching and stepping movements based on a combined Virtual Reality (VR)/ kinematic system.
Time Frame
Baseline
Title
Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) to measure upper extremity function (only for SCI)
Time Frame
The outcome is used for 2 sub-projects of this study: one sub-project conducts GRASSP at > 12 months after spinal cord injury, whereas the other sub-project conducts GRASSP at 3 visits (at < 1, 3 and 6 months after spinal cord injury).
Title
International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) (only for SCI)
Time Frame
The outcome is used for 2 sub-projects of this study: one sub-project conducts ISNCSCI at > 12 months after spinal cord injury, whereas the other sub-project conducts ISNCSCI at 3 visits (at < 1, 3 and 6 months after spinal cord injury).
Title
10-meter walk test (only for SCI)
Time Frame
Baseline
Title
6-minute walk test (only for SCI)
Time Frame
Baseline
Title
Modified Ashworth Scale (MAS) (only for SCI)
Time Frame
Baseline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Written informed consent as documented by signature For SCI patients: ASIA Impairment scale (AIS) A-D Focal damage at cervical (C4-C7; i.e. damage rostral of the spi-nal segments innervating the examined hand and leg muscles) or thoracic (T4-T12; i.e. damage caudal of the spinal segments innervating the m. abductor digiti minimi, but rostral of the spi-nal segments innervating the m. tibialis anterior) Patients with cervical SCI must reveal bilaterally intact ulnar nerves as demonstrated by normal compound motor action potential (cMAP), nerve conduction velocity (NCV) and F-wave latencies in clinical neurography. Patients with thoracic SCI must reveal bilaterally intact tibial and peroneal nerves as demonstrated by normal cMAP, NCV and F-wave latencies Exclusion Criteria: Women who are pregnant or breast feeding Current neurological problems other than SCI and related impairments Current orthopaedic problems affecting upper and lower extremity movements History of alcohol abuse or the intake of psychotropic drugs History of major cardiac condition (e.g., infarction, insufficiency (NYHA II-IV)) History of major pulmonary condition (e.g., chronic obstructive pulmonary disease (GOLD II-IV)) Current major depression or psychosis Fever of unknown origin
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Linard Filli, Dr.
Phone
+41 44 510 72 12
Email
linard.filli@balgrist.ch
Facility Information:
Facility Name
Balgrist University Hospital
City
Zürich
ZIP/Postal Code
8008
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Linard Filli, Dr.
Phone
+41 44 510 72 12
Email
linard.filli@balgrist.ch
First Name & Middle Initial & Last Name & Degree
Curt Armin, Prof. Dr.

12. IPD Sharing Statement

Learn more about this trial

Reticulospinal Control of Movements

We'll reach out to this number within 24 hrs